Unicycive Therapeutics: Advancing Breakthroughs in Kidney Disease Therapies
2 years ago
A biotech dedicated to developing treatments for unmet medical needs, Unicycive Therapeutics (NASDAQ: UNCY) is currently advancing two programs focused on kidney disease and intends to expand its pipeline to target additional indications within and outside kidney disease. Unicycive is preparing to commercialize and launch its lead therapy, Renazorb, for treatment of hyperphosphatemia in patients with chronic kidney disease and is continuing development of UNI 494 for treatment of acute kidney injury. Visit UNCYinfo.com to learn more.
Loading comments...
-
1:04:17
Timcast
2 hours agoGOP SHUTS House Votes BLOCKING Massie/Khanna Epstein Files Release
106K102 -
11:57
Michael Button
4 hours agoAre We Missing an Ancient Sea-Faring Culture?
1001 -
1:43:50
The Confessionals
2 hours agoNavy Pilot’s Drug Bust Mission Turns UFO Chase Over Open Ocean (Then It Went Underwater)
123 -
LIVE
StoneMountain64
1 hour agoBattlefield 6 CONFIRMED + Delta Force Escaping PRISON with PROS
219 watching -
LIVE
ROSE UNPLUGGED
15 hours agoInside Trump’s Game-Changing Law
34 watching -
1:12:06
The Rubin Report
3 hours agoHost Can’t Believe What Hunter Biden Admitted During Insane Interview That’s Going Viral Now
108K44 -
2:09:20
Benny Johnson
4 hours ago🚨Ghislaine Maxwell Breaks SILENCE: Will Expose EVERYTHING on Epstein Clients | We Have Inside Scoop
77.6K103 -
1:28:19
Nikko Ortiz
2 hours agoLive - Unwatchable Clips
17.3K3 -
1:04:28
The Dr. Ardis Show
3 hours ago $1.34 earnedThe Dr. Ardis Show | Weather Modification and Chemtrails with Dane Wigington | Episode 07.22.2025
4.07K10 -
LIVE
TheAlecLaceShow
2 hours agoGuests: Senator Tuberville, Mike Howell, Jim Pfaff | Russiagate | Epstein | The Alec Lace Show
143 watching